DR REDDYS LABORATORIES
Back to All Ratios
|
DR REDDYS LABORATORIES Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 17.54 | 19.91 | 18.27 | 10.13 | 10.25 |
What is the latest Profit After Tax (PAT) Margin ratio of DR REDDYS LABORATORIES ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 17.54 |
| Mar2024 | 19.91 |
| Mar2023 | 18.27 |
| Mar2022 | 10.13 |
| Mar2021 | 10.25 |
How is Profit After Tax (PAT) Margin of DR REDDYS LABORATORIES Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 17.54 | -11.90 | |
| Mar2024 | 19.91 | 8.98 | |
| Mar2023 | 18.27 | 80.36 | |
| Mar2022 | 10.13 | -1.17 | |
| Mar2021 | 10.25 | - | |
Other Financial Ratios of DR REDDYS LABORATORIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹104,542.0 Cr | -2.1% | -0% | -2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,822.0 Cr | 1.6% | 8.2% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,811.0 Cr | -0.8% | 14.4% | 12.2% | Stock Analytics | |
| CIPLA | ₹127,688.0 Cr | -3.9% | 5.5% | 5.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,840.0 Cr | -0.5% | 1% | 7.9% | Stock Analytics | |
| MANKIND PHARMA | ₹100,903.0 Cr | -0.2% | -1.5% | -4.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -2.1% |
-0% |
-2% |
| SENSEX | 0.7% |
4.7% |
6.1% |
You may also like the below Video Courses